资讯

Azithromycin is a commonly prescribed antibiotic in the United States. It is used to treat bacterial infections such as STIs, pneumonia, respiratory, skin, and throat infections.
When azithromycin is prescribed for sinusitis, it is often prescribed as a "Z-pak," a five-day course of azithromycin which many patients find convenient. While the Infectious Diseases Society of ...
A total of 2,802 patients with COPD were randomised 1:1 to receive FF/VI 100/25mcg, with or without a long-acting muscarinic antagonist (LAMA), or to continue to receive usual care.
New study results with GSK's anti-IL-5 antibody Nucala in chronic obstructive pulmonary disease (COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th May.
The study, known as Safety and Antimicrobial Resistance of Mass Administration of Azithromycin Among Children (SARMAAN), was initiated in line with the World Health Organization’s 2022 guidelines.
Conclusion. Results of the single dose azithromycin trials reviewed here demonstrate that this regimen is safe and effective and results in excellent compliance in children with uncomplicated AOM.
COPD — chronic obstructive pulmonary disease — “is a tough disease,” says Colleen Brennan-Martinez, 64, a retired nurse practitioner from New York City whose father, James Brennan, died from COPD in ...
LABAs are central to the management of COPD and the prevention of further exacerbations. [ 38 , 52 ] Also, new long-acting agents are in development, including LABA and LAMA combination therapies.
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.
Compared with those who tested negative, individuals with COPD who tested positive for COVID-19 had 9% overall higher HCU rates (rate ratio [RR], 1.096; 95% CI, 1.067-1.127), as well as a 13% higher ...
EUROPEAN surveillance data from 2022 show a sharp rise in antimicrobial resistance (AMR) in Neisseria gonorrhoeae, raising new concerns about treatment efficacy for this common sexually transmitted ...
For COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher, MD, MHS, of Duke University in Durham, North Carolina.